-
Biocon S&P Global ESG score improves to 69 for 2024
27 Jan 2025 08:57 GMT
… percentile among its global biotechnology industry peers. Biocon achieved an ESG … & Economic Dimension.
Biocon’s subsidiary Biocon Biologics Limited, which also … robust ESG governance structure, Biocon has consistently integrated sustainability principles …
-
Biocon Biologics Secures Regulatory Approval for Ustekinumab BS
15 Jan 2025 10:50 GMT
… this approval from PMDA, Biocon Biologics is now authorized … Japan by Yoshindo Inc., Biocon Biologics’ exclusive partner in … is expected to strengthen Biocon Biologics’ foothold in the … Biocon Biologics’ settlement and licensing agreement with Janssen Biotech …
-
PM Anwar touts his govt’s policies, strong economic indicators for continuing foreign investor run after Biocon Biologics sinks US$350m into Malaysia
08 Jan 2025 02:05 GMT
… LUMPUR, Jan 8 — Biocon Biologics is committed to … business expansion in Malaysia. Biocon Biologics is a global company … a courtesy visit from Biocon Biologics executive chairman Kiran … initiatives to advance local biotechnology capabilities that also involve …
-
Business : Biocon Biologics Is Committed To Business Development In Malaysia - PM Anwar
07 Jan 2025 15:42 GMT
… implementing business expansion in Malaysia. Biocon Biologics is a global company … received a courtesy visit from Biocon Biologics executive chairman Kiran Mazumdar … on initiatives to advance local biotechnology capabilities that also involve the …
-
Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade
07 Jan 2025 10:52 GMT
… Vulgaris and Psoriatic Arthritis (PsA).
Biocon Biologics previously notified the stock … and licensing agreement with Janssen Biotech Inc., Janssen Sciences Ireland, … and Drug Administration (USFDA) granted Biocon Biologics' Bengaluru facility “Voluntary …
-
Biocon Biologics secures PMDA approval for Ustekinumab biosimilar in Japan
07 Jan 2025 05:01 GMT
… PMDA’s approval allows Biocon Biologics to market Ustekinumab … Japan by Yoshindo Inc., Biocon Biologics’ exclusive partner … is expected to strengthen Biocon Biologics’ foothold in the … Biocon Biologics’ settlement and licensing agreement with Janssen Biotech …
-
Biocon shares rise 3% as subsidiary secures Japanese PMDA approval for Ustekinumab biosimilar
07 Jan 2025 04:48 GMT
… NSE.
Key Highlights:
Regulatory Approval: Biocon Biologics received approval to market … in collaboration with Yoshindo Inc., Biocon Biologics’ exclusive partner in the … : The approval follows Biocon Biologics’ licensing agreement with Janssen Biotech Inc. and …
-
Itolizumab by Biocon for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
30 Dec 2024 18:27 GMT
… nephritis and severe asthma.
Biocon overview
Biocon is a biopharmaceutical company. It … small and large molecules for biotechnology and pharmaceutical companies across the … Switzerland, the UAE, and Malaysia. Biocon is headquartered in Bangalore, Karnataka …
-
'Amazing discovery': Biocon's Kiran Mazumdar-Shaw says THIS drug will disrupt dentistry for sure
15 Dec 2024 08:56 GMT
Biocon Executive Chairperson Kiran Mazumdar-Shaw … , developed by researchers at Japanese biotech firm Toregem Biopharma, targets a …
-
Biocon sells 80 lacs equity shares of Syngene International for Rs 686 crores
12 Dec 2024 16:25 GMT
… consecutive year for Biocon and subsequently its subsidiary Biocon Biologics to … , Plaque Psoriasis, Psoriatic Arthritis
Biocon Limited, publicly listed in 2004 … company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer …